FINANCIAL STATEMENTS AND OTHER INFORMATION 140 NOTES TO THE SUMMARY COMBINED FINANCIAL INFORMATION IN EUROS Notes to the summary combined financial information in euros 1 Segment analysis ANALYSIS BY BUSINESS SEGMENT Revenue Operating profit Adjusted operating profit Restated Restated 2014 2013 2014 2013 2014 2013 m m m m m m scientific, Technical & Medical 2,540 2,509 848 817 945 929 Risk & Business Information 1,784 1,746 467 436 627 598 Legal 1,731 1,849 214 190 322 295 Exhibitions 1,104 1,017 216 187 269 248 Sub-total 7,159 7,121 1,745 1,630 2,163 2,070 Corporate costs 7 6 7 6 Total 7,159 7,121 1,738 1,624 2,156 2,064 Share of post-tax results of joint ventures of 44m 2013: 35m included in operating profit comprises 20m 2013: 7m relating to Legal and 24m 2013: 28m relating to Exhibitions.
ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN 2014 2013 m m North America 3,576 3,661 United Kingdom 1,256 1,162 The Netherlands 789 774 Rest of Europe 851 824 Rest of world 687 700 Total 7,159 7,121 ANALYSIS OF REVENUE BY GEOGRAPHICAL MARKET 2014 2013 m m North America 3,569 3,637 United Kingdom 564 523 The Netherlands 190 196 Rest of Europe 1,306 1,267 Rest of world 1,530 1,498 Total 7,159 7,121 ANALYSIS OF REVENUE BY FORMAT 2014 2013 m m Electronic 4,761 4,686 Print 1,255 1,378 Face-to-face 1,143 1,057 Total 7,159 7,121 94118 Reed AR p135-145.
indd 140 06 03 2015 13:15 Overview Business review Financial review Governance Financial statements and other information RELX Group Annual Reports and Financial Statements 2014 141 1 Segment analysis continued ANALYSIS OF REVENUE BY TYPE 2014 2013 m m Subscriptions 3,678 3,672 Transactional 3,313 3,166 Advertising 168 283 Total 7,159 7,121 ANALYSIS BY BUSINESS SEGMENT Expenditure on Capital Amortisation acquired goodwill and expenditure of acquired Depreciation and intangible assets additions intangible assets other amortisation Restated Restated 2014 2013 2014 2013 2014 2013 2014 2013 m m m m m m m m scientific, Technical & Medical 31 59 69 110 98 101 116 118 Risk & Business Information 409 199 66 51 144 151 42 39 Legal 59 18 180 200 71 76 117 119 Exhibitions 29 66 33 18 42 47 19 18 Total 528 342 348 379 355 375 294 294 Capital expenditure comprises additions to property, plant and equipment and internally developed intangible assets.
Amortisation of acquired intangible assets includes amounts in respect of joint ventures of 4m 2013: nil in Legal and 1m 2013: 1m in Exhibitions.
Other than the depreciation and amortisation above, non cash items include 40m 2013: 37m relating to the recognition of share based remuneration and comprise 14m 2013: 13m in scientific, Technical & Medical, 10m 2013: 10m in Risk & Business Information, 9m 2013: 8m inLegal and 7m 2013: 6m in Exhibitions.
ANALYSIS OF NONCURRENT ASSETS BY GEOGRAPHICAL LOCATION 2014 2013 m m North America 8,474 7,549 United Kingdom 904 701 The Netherlands 140 150 Rest of Europe 1,053 904 Rest of world 534 481 Total 11,105 9,785 Non-current assets by geographical location exclude amounts relating to deferred tax assets and derivative financial instruments.
